Insider Transactions in Q3 2022 at Natus Medical Inc (NTUS)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2022
|
Alice D. Schroeder Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,406
-100.0%
|
$739,398
$33.5 P/Share
|
|
Jul 21
2022
|
Thomas Joseph Sullivan President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
720,903
-100.0%
|
$23,789,799
$33.5 P/Share
|
|
Jul 21
2022
|
Thomas Joseph Sullivan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
648,554
+47.36%
|
-
|
|
Jul 21
2022
|
Austin Francis Noll Iii Executive VP and CCO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
200,509
-100.0%
|
$6,616,797
$33.5 P/Share
|
|
Jul 21
2022
|
Austin Francis Noll Iii Executive VP and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
61,966
+23.61%
|
-
|
|
Jul 21
2022
|
Bryant M Moore Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,114
-100.0%
|
$333,762
$33.5 P/Share
|
|
Jul 21
2022
|
Joshua Levine Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,387
-100.0%
|
$1,233,771
$33.5 P/Share
|
|
Jul 21
2022
|
Lisa Wipperman Heine Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,287
-100.0%
|
$867,471
$33.5 P/Share
|
|
Jul 21
2022
|
Eric Guerin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,114
-100.0%
|
$333,762
$33.5 P/Share
|
|
Jul 21
2022
|
Benjamin Drew Davies Executive VP and CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
181,846
-100.0%
|
$6,000,918
$33.5 P/Share
|
|
Jul 21
2022
|
Benjamin Drew Davies Executive VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
106,034
+36.83%
|
-
|
|
Jul 21
2022
|
Ilan Daskal Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,937
-100.0%
|
$624,921
$33.5 P/Share
|
|
Jul 21
2022
|
Dong Chune Christopher Chung Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
83,374
-100.0%
|
$2,751,342
$33.5 P/Share
|
|
Jul 21
2022
|
Dong Chune Christopher Chung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,056
+29.6%
|
-
|